Report Detail

Request for Sample of this report

Other Global Heparin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2867112
    • |
  • 04 February, 2019
    • |
  • Global
    • |
  • 120 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine

Scope of the Report:
Heparin API is an anticoagulant (blood thinner) that prevents the formation of blood clots. With the accelerated pace of life and increasing aging population, global morbidity and mortality of cardiovascular and cerebrovascular disease are increased year by year. Heparin API is an efficient solution to those diseases.

Raw materials of Heparin API are mainly porcine intestine, bovine lung and bovine intestine, etc. China pig slaughter amount accounted for more than 50% of the world. It has most abundant raw material resources all over the world.

The classification of Heparin includes Heparin Sodium, Heparin Calcium and others, and the proportion of Heparin Sodium in 2016 is about 88%, and the proportion is in decreasing trend from 2012 to 2016.

Heparin is widely used UFH and LMWH. The most proportion of Heparin is used in LMWH, and the proportion in 2016 is 88.9%

Europe is the largest consumption place, with a consumption market share nearly 40% in 2016. Following Europe, United Stated is the second largest consumption place with the consumption market share of 36%.

Market competition is not intense. Hepalink, Bioibérica, Changshan Pharm, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.

The worldwide market for Heparin is expected to grow at a CAGR of roughly 3.3% over the next five years, will reach 1200 million US$ in 2024, from 990 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Heparin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioibérica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma Limited
Deebio

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Heparin Sodium
Heparin Calcium
Other

Market Segment by Applications, can be divided into
UFH
LMWH

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Heparin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Heparin, with price, sales, revenue and global market share of Heparin in 2017 and 2018.
Chapter 3, the Heparin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Heparin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Heparin market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Heparin sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Heparin Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Heparin Sodium
      • 1.2.2 Heparin Calcium
      • 1.2.3 Other
    • 1.3 Market Analysis by Applications
      • 1.3.1 UFH
      • 1.3.2 LMWH
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Hepalink
      • 2.1.1 Business Overview
      • 2.1.2 Heparin Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Hepalink Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Changshan Pharm
      • 2.2.1 Business Overview
      • 2.2.2 Heparin Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Changshan Pharm Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Qianhong Bio-pharma
      • 2.3.1 Business Overview
      • 2.3.2 Heparin Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Qianhong Bio-pharma Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Opocrin
      • 2.4.1 Business Overview
      • 2.4.2 Heparin Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Opocrin Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Pfizer
      • 2.5.1 Business Overview
      • 2.5.2 Heparin Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Pfizer Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Aspen Oss
      • 2.6.1 Business Overview
      • 2.6.2 Heparin Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Aspen Oss Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 King-friend Biochemical Pharmaceutical
      • 2.7.1 Business Overview
      • 2.7.2 Heparin Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 King-friend Biochemical Pharmaceutical Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Bioibérica
      • 2.8.1 Business Overview
      • 2.8.2 Heparin Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Bioibérica Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Dongcheng Biochemicals
      • 2.9.1 Business Overview
      • 2.9.2 Heparin Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Dongcheng Biochemicals Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Jiulong Biochemicals
      • 2.10.1 Business Overview
      • 2.10.2 Heparin Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Jiulong Biochemicals Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Tiandong
      • 2.11.1 Business Overview
      • 2.11.2 Heparin Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Tiandong Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Xinbai
      • 2.12.1 Business Overview
      • 2.12.2 Heparin Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Xinbai Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Yino Pharma Limited
      • 2.13.1 Business Overview
      • 2.13.2 Heparin Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Yino Pharma Limited Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Deebio
      • 2.14.1 Business Overview
      • 2.14.2 Heparin Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Deebio Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Heparin Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Heparin Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Heparin Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Heparin Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Heparin Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Heparin Market Analysis by Regions

    • 4.1 Global Heparin Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Heparin Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Heparin Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Heparin Sales and Growth Rate (2014-2019)
    • 4.3 Europe Heparin Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Heparin Sales and Growth Rate (2014-2019)
    • 4.5 South America Heparin Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Heparin Sales and Growth Rate (2014-2019)

    5 North America Heparin by Country

    • 5.1 North America Heparin Sales, Revenue and Market Share by Country
      • 5.1.1 North America Heparin Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Heparin Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Heparin Sales and Growth Rate (2014-2019)
    • 5.3 Canada Heparin Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Heparin Sales and Growth Rate (2014-2019)

    6 Europe Heparin by Country

    • 6.1 Europe Heparin Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Heparin Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Heparin Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Heparin Sales and Growth Rate (2014-2019)
    • 6.3 UK Heparin Sales and Growth Rate (2014-2019)
    • 6.4 France Heparin Sales and Growth Rate (2014-2019)
    • 6.5 Russia Heparin Sales and Growth Rate (2014-2019)
    • 6.6 Italy Heparin Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Heparin by Country

    • 7.1 Asia-Pacific Heparin Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Heparin Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Heparin Revenue and Market Share by Country (2014-2019)
    • 7.2 China Heparin Sales and Growth Rate (2014-2019)
    • 7.3 Japan Heparin Sales and Growth Rate (2014-2019)
    • 7.4 Korea Heparin Sales and Growth Rate (2014-2019)
    • 7.5 India Heparin Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Heparin Sales and Growth Rate (2014-2019)

    8 South America Heparin by Country

    • 8.1 South America Heparin Sales, Revenue and Market Share by Country
      • 8.1.1 South America Heparin Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Heparin Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Heparin Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Heparin Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Heparin Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Heparin by Countries

    • 9.1 Middle East and Africa Heparin Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Heparin Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Heparin Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Heparin Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Heparin Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Heparin Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Heparin Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Heparin Sales and Growth Rate (2014-2019)

    10 Global Heparin Market Segment by Type

    • 10.1 Global Heparin Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Heparin Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Heparin Revenue and Market Share by Type (2014-2019)
    • 10.2 Heparin Sodium Sales Growth and Price
      • 10.2.1 Global Heparin Sodium Sales Growth (2014-2019)
      • 10.2.2 Global Heparin Sodium Price (2014-2019)
    • 10.3 Heparin Calcium Sales Growth and Price
      • 10.3.1 Global Heparin Calcium Sales Growth (2014-2019)
      • 10.3.2 Global Heparin Calcium Price (2014-2019)
    • 10.4 Other Sales Growth and Price
      • 10.4.1 Global Other Sales Growth (2014-2019)
      • 10.4.2 Global Other Price (2014-2019)

    11 Global Heparin Market Segment by Application

    • 11.1 Global Heparin Sales Market Share by Application (2014-2019)
    • 11.2 UFH Sales Growth (2014-2019)
    • 11.3 LMWH Sales Growth (2014-2019)

    12 Heparin Market Forecast (2019-2024)

    • 12.1 Global Heparin Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Heparin Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Heparin Market Forecast (2019-2024)
      • 12.2.2 Europe Heparin Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Heparin Market Forecast (2019-2024)
      • 12.2.4 South America Heparin Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Heparin Market Forecast (2019-2024)
    • 12.3 Heparin Market Forecast by Type (2019-2024)
      • 12.3.1 Global Heparin Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Heparin Market Share Forecast by Type (2019-2024)
    • 12.4 Heparin Market Forecast by Application (2019-2024)
      • 12.4.1 Global Heparin Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Heparin Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Heparin . Industry analysis & Market Report on Heparin is a syndicated market report, published as Global Heparin Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Heparin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,773.56
      		4,160.34
      		5,547.12
      		3,232.92
      		4,849.38
      		6,465.84
      		533,240.40
      		799,860.60
      		1,066,480.80
      		290,371.20
      		435,556.80
      		580,742.40
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo